Sunday, July 28, 2019

This week in Pharma: Potential Pfizer-Mylan deal could begin consolidation of generic industry

This week in Pharma: Potential Pfizer-Mylan deal could begin consolidation of generic industry The combined entity after the merger of Pfizer#39;s off-patent business and Mylan would become the largest generic drug maker globally, and may set the pace for the consolidation of an industry facing pricing pressure amidst competition and channel consolidation in US market.

from Moneycontrol Business News https://ift.tt/2Yda5kf
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Global Market Today: Asian stocks hit record highs, oil heads for weekly loss

Asian stocks reached a record high, fueled by optimism that the reopening of the Strait of Hormuz will normalize oil flows and ease inflatio...